HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 89 filers reported holding HARVARD BIOSCIENCE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,265 | -33.5% | 4,015 | -15.1% | 0.00% | – |
| Q2 2023 | $25,963 | +8.2% | 4,729 | +22.8% | 0.00% | – |
| Q1 2022 | $24,000 | -11.1% | 3,851 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -15.6% | 3,851 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | +77.8% | 3,851 | +15.6% | 0.00% | – |
| Q1 2021 | $18,000 | +28.6% | 3,330 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 3,330 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -33.3% | 3,330 | -30.4% | 0.00% | – |
| Q2 2020 | $15,000 | +50.0% | 4,782 | -8.5% | 0.00% | – |
| Q2 2019 | $10,000 | -56.5% | 5,226 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +35.3% | 5,226 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -37.0% | 5,226 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -3.6% | 5,226 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | – | 5,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |